BioQuest

BioQuest Financing Cash Flow

The Net Financing Cash Flow of BioQuest (BQST) as of Oct 22, 2026 is 300,000.00 USD. In the previous year, Net Financing Cash Flow was 742,405.00 USD — a change of -59.59% (lower).

Financing Cash Flow

300,000.00USD

YoY

-59.59%

Last updated:

Net Financing Cash Flow of BioQuest is 2026 300,000.00 USD. Net Financing Cash Flow of BioQuest was 2025 742,405.00 USD. It decreases by -59.59% lower compared to the previous year.

The BioQuest Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2019
125,000.00 USD
Jan 1, 2020
125,000.00 USD
Jan 1, 2021
193,300.00 USD
Jan 1, 2022
150,000.00 USD
Jan 1, 2023
20,000.00 USD
Jan 1, 2024
35,000.00 USD
Jan 1, 2025
742,405.00 USD
Jan 1, 2026
300,000.00 USD
The BioQuest Financing Cash Flow history
YEARFinancing Cash FlowYoY
300,000.00USD-59.59%
742,405.00USD+2,021.16%
35,000.00USD+75.00%
20,000.00USD-86.67%
150,000.00USD-22.40%
193,300.00USD+54.64%
125,000.00USD0.00%
125,000.00USD-89.00%
1.14 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioQuest Stock analysis

What does BioQuest do? BioQuest Corp. makes money through acquiring companies in the green energy sector, such as Progressus Clean Technologies, Inc., which focuses on hydrogen generation and separation technologies. The company executes letters of intent to acquire private firms like Progressus, which owns intellectual property for extracting hydrogen from gas streams. Progressus has not generated any revenue, but BioQuest aims to monetize its acquisitions by developing and commercializing these technologies. BioQuest targets investors seeking exposure to emerging green energy technologies through its acquisition strategy. BioQuest Corp. operates in the green energy sector, specifically targeting venture-stage companies with innovative technologies. The firm's primary product is the acquisition of companies like Progressus, which holds intellectual property for hydrogen extraction. BioQuest does not generate revenue from its own operations but relies on the future revenue potential of acquired companies. The company's business model centers on identifying and acquiring early-stage green technology firms with scalable intellectual property. The company's focus on acquiring private companies such as Progressus Clean Technologies, Inc., which is developing hydrogen generation and separation technologies, positions BioQuest to capitalize on the growing demand for clean energy solutions. Progressus's intellectual property for extracting hydrogen from gas streams represents a key asset that BioQuest aims to leverage. BioQuest Corp. targets investors interested in the green energy sector through its strategic acquisitions, expecting future revenue from the commercialization of these technologies. BioQuest is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioQuest stock

Net Financing Cash Flow of BioQuest is 300,000.00 USD in 2026.

Net Financing Cash Flow of BioQuest changed from 742,405.00 USD to 300,000.00 USD, representing a -59.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow BioQuest since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's BioQuest historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — BioQuest

All Key Metrics — BioQuest